Wenhui Mo

1.7k total citations
43 papers, 1.3k citations indexed

About

Wenhui Mo is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Wenhui Mo has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Hepatology. Recurrent topics in Wenhui Mo's work include Cancer, Hypoxia, and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA modifications and cancer (5 papers). Wenhui Mo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA modifications and cancer (5 papers). Wenhui Mo collaborates with scholars based in China, United States and United Kingdom. Wenhui Mo's co-authors include Chuanyong Guo, Jingjing Li, Sainan Li, Kan Chen, Liwei Wu, Jiao Feng, Qiang Yu, Weiqi Dai, Yujing Xia and Ling Xu and has published in prestigious journals such as PLoS ONE, Scientific Reports and British Journal of Cancer.

In The Last Decade

Wenhui Mo

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenhui Mo China 17 651 414 337 226 133 43 1.3k
Shizan Xu China 22 570 0.9× 321 0.8× 389 1.2× 275 1.2× 148 1.1× 26 1.3k
Feixia Wang China 20 554 0.9× 269 0.6× 397 1.2× 278 1.2× 95 0.7× 42 1.2k
Marta B. Afonso Portugal 18 734 1.1× 419 1.0× 681 2.0× 195 0.9× 187 1.4× 44 1.4k
Shanzhong Tan China 19 738 1.1× 423 1.0× 431 1.3× 278 1.2× 74 0.6× 40 1.4k
Desong Kong China 24 796 1.2× 417 1.0× 582 1.7× 464 2.1× 138 1.0× 51 1.8k
Zhi Dai China 20 975 1.5× 370 0.9× 653 1.9× 132 0.6× 189 1.4× 59 1.9k
Taichiro Nishikawa Japan 24 543 0.8× 211 0.5× 714 2.1× 395 1.7× 239 1.8× 46 1.6k
Elena Piccinin Italy 15 455 0.7× 213 0.5× 333 1.0× 92 0.4× 164 1.2× 35 1.1k
Ping Cheng China 20 468 0.7× 147 0.4× 319 0.9× 216 1.0× 132 1.0× 27 1.1k
Laura Conde de la Rosa United States 18 515 0.8× 150 0.4× 458 1.4× 258 1.1× 201 1.5× 23 1.3k

Countries citing papers authored by Wenhui Mo

Since Specialization
Citations

This map shows the geographic impact of Wenhui Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhui Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhui Mo more than expected).

Fields of papers citing papers by Wenhui Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenhui Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhui Mo. The network helps show where Wenhui Mo may publish in the future.

Co-authorship network of co-authors of Wenhui Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Wenhui Mo. A scholar is included among the top collaborators of Wenhui Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenhui Mo. Wenhui Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mo, Wenhui, et al.. (2025). Metabolomics in autoimmune hepatitis: progress and perspectives. Frontiers in Medicine. 12. 1667391–1667391.
2.
Mo, Wenhui, et al.. (2025). Extracellular vesicles in autoimmune diseases: Mechanistic underpinnings and precision medicine applications. Autoimmunity Reviews. 25(2). 103959–103959.
3.
Zhuang, Ruiyuan, Yuxin Wang, Junhong Wang, et al.. (2025). Hierarchical SnS2@CNFs composite with 3D structure for high-performance aluminum-ion batteries: Unveiling Al3+ deintercalation mechanism through first-principles calculations. Journal of Alloys and Compounds. 1034. 181295–181295. 2 indexed citations
4.
Zou, Rong, et al.. (2025). High-fat diet alters retinal lipid composition and gene expression networks in mice. BMC Biology. 23(1). 103–103. 2 indexed citations
6.
Li, Jingjing, Weiqi Dai, Wenhui Mo, et al.. (2023). Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 13 indexed citations
8.
Kociolek, John Patrick, et al.. (2022). Two new freshwater species of Surirella (Bacillariophyta) from the Wuling Mountains, China. PhytoKeys. 201. 35–49. 1 indexed citations
9.
Mo, Wenhui, Jianlan Wang, Qi Zhang, et al.. (2022). Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 48(1). 111–111. 3 indexed citations
10.
Feng, Jiao, Weiqi Dai, Yuqing Mao, et al.. (2020). Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis. Journal of Experimental & Clinical Cancer Research. 39(1). 24–24. 169 indexed citations
11.
Ji, Jie, Liwei Wu, Jiao Feng, et al.. (2020). Cafestol preconditioning attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting ERK/PPARγ pathway. International Immunopharmacology. 84. 106529–106529. 26 indexed citations
13.
Mo, Wenhui, et al.. (2020). <p>Long Noncoding RNA (lncRNA) MT1JP Suppresses Hepatocellular Carcinoma (HCC) in vitro</p>. Cancer Management and Research. Volume 12. 7949–7960. 8 indexed citations
14.
Mo, Wenhui, Chengfen Wang, Jingjing Li, et al.. (2018). Fucosterol Protects against Concanavalin A-Induced Acute Liver Injury: Focus on P38 MAPK/NF-κB Pathway Activity. Gastroenterology Research and Practice. 2018. 1–13. 30 indexed citations
15.
Feng, Jiao, Qinghui Zhang, Wenhui Mo, et al.. (2017). Salidroside pretreatment attenuates apoptosis and autophagy during hepatic ischemia&ndash;reperfusion injury by inhibiting the mitogen-activated protein kinase pathway in mice. Drug Design Development and Therapy. Volume 11. 1989–2006. 53 indexed citations
16.
Wu, Liwei, Qinghui Zhang, Wenhui Mo, et al.. (2017). Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways. Scientific Reports. 7(1). 9289–9289. 214 indexed citations
17.
Xu, Shizan, Kan Chen, Yujing Xia, et al.. (2017). The liver protection of propylene glycol alginate sodium sulfate preconditioning against ischemia reperfusion injury: focusing MAPK pathway activity. Scientific Reports. 7(1). 15175–15175. 35 indexed citations
18.
Mo, Wenhui, Xuanfu Xu, Ling Xu, et al.. (2011). Resveratrol Inhibits Proliferation and Induces Apoptosis through the Hedgehog Signaling Pathway in Pancreatic Cancer Cell. Pancreatology. 11(6). 601–609. 58 indexed citations
19.
Xu, Ling, Feng Wang, Hua Liu, et al.. (2010). Increased Expression of Cellular Repressor of E1A-Stimulated Gene (CREG) in Gastric Cancer Patients: A Mechanism of Proliferation and Metastasis in Cancer. Digestive Diseases and Sciences. 56(6). 1645–1655. 10 indexed citations
20.
Xu, Ling, Feng Wang, Xuanfu Xu, et al.. (2010). Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells. Medical Oncology. 28(S1). 189–196. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026